Ozempic, which has been in the headlines, with celebrities allegedly using it for shocking weight loss, is facing thousands of lawsuits for blind loss.
A growing number of complaints filed against Ozempic creators Novo Nordisk and Eli Lilly, claiming they lost some or all of their eyesight while taking the companies’ blockbuster weight loss drugs, before courts.
People are filing Ozempic lawsuits after experiencing gastrointestinal injuries and blood clots after taking the drug.
What is Ozempic?
Ozempic (semaglutide) is a GLP-1 drug approved by the U.S. Food and Drug Administration (FDA) to help treat patients with type 2 diabetes. Moreover, a well-publicised side effect of the weekly injection is that it may help people lose weight.
With increased use of the drug, concern has risen that prolonged use may lead to serious gastrointestinal injuries and other long-term issues.
Ozempic lawsuits claim
- Stomach paralysis/gastroparesis
- Bowel blockage/ileus
- Blindness (NAION)/vision problems
- Blood clots/deep vein thrombosis (DVT)
- Pulmonary embolism (PE) or pulmonary aspiration
- Gallbladder conditions
- Pancreatic conditions
Ozempic Lawsuit Latest Update.
According to details, gastroparesis is the most frequently listed injury in complaints filed as part of the GLP-1 product liability litigation (MDL -3094), which includes Ozempic claims.
In a hearing on January 13, 2026, Novo Nordisk’s attorney Katie Insogna gave a breakdown of injuries listed in lawsuits in the MDL. 75% of the lawsuits listed gastroparesis/stomach paralysis in the complaint, 18% listed ileus, 8% listed gallbladder complications, and 8% listed other severe gastrointestinal conditions.
Novo Nordisk approved
The U.S. Food and Drug Administration earlier approved Novo Nordisk’s GLP-1 weight-loss pill Wegovy, widening access to medicines that help people eat less by suppressing appetite.
The approval was quickly followed by a dip in the share prices of several food companies, underlining investor worries that lower food consumption could hurt future sales. The reaction suggests the market increasingly views weight-loss drugs as a challenge not just for healthcare systems, but for the food industry as a whole.
Pakistani celebrities using Ozempic?
Pakistani comedian and outspoken actor Yasir Hussain took to his Instagram and poked fun at celebrities who he knows have used #Ozempic to lose weight but don’t seem to be affected by its negative effects, basically because they are refusing to admit that they have used it!
